*The microdeletion region is the same for Angelman and Prader-Willi syndromes (15q11.2). The NACE® Extended 24 test cannot distinguish between these two syndromes. An additional test is required to confirm the syndrome in question.
Ocasionally, the optimal day to perform the transfer may be displaced. This condition is referred as a displaced window of implantation (WOI).
Igenomix is in the media
Igenomix is not affiliated with any news outlet or publication identified above. News coverage does not constitute an endorsement of Igenomix or its products.
In accordance with Organic Law 15/1999 of 13 December on Personal Data Protection, we hereby inform you that your personal data will be incorporated to files belonging to IGENOMIX, S.L., in order to address your inquiry and contact you to arrange and manage your request. In addition, your contact details may be subsequently used to send out information about our products and services which could be of your interest.
Data holders consent to the treatment of the data provided, guaranteeing and protecting the freedoms and rights marked by current legislation.
The owners of the data consent to the processing of the data provided, thereby guaranteeing and protecting the freedoms and rights defined in the legislation in force.
The owner of the data is entitled to exercise the rights of access, rectification, cancellation and objection by means of written communication and attached National ID Card addressed to Igenomix at the following address: C/ Catedrático Agustín Escardino, 9 del Parc Cientific Univertsitat de València, 46980 Paterna – Valencia – España or by sending an email to email@example.com
This company guarantees that adequate measures will be adopted to ensure the confidential handling of this data.